α‐Emitting cancer therapy using (211)At‐AAMT targeting LAT1

α‐Methyl‐l‐tyrosine (AMT) has a high affinity for the cancer‐specific l‐type amino acid transporter 1 (LAT1). Therefore, we established an anti‐cancer therapy, with (211)At‐labeled α‐methyl‐l‐tyrosine ((211)At‐AAMT) as a carrier of (211)At into tumors. (211)At‐AAMT had high affinity for LAT1, inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneda‐Nakashima, Kazuko, Zhang, ZiJian, Manabe, Yoshiyuki, Shimoyama, Atsushi, Kabayama, Kazuya, Watabe, Tadashi, Kanai, Yoshikatsu, Ooe, Kazuhiro, Toyoshima, Atsushi, Shirakami, Yoshifumi, Yoshimura, Takashi, Fukuda, Mitsuhiro, Hatazawa, Jun, Nakano, Takashi, Fukase, Koichi, Shinohara, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935802/
https://www.ncbi.nlm.nih.gov/pubmed/33277750
http://dx.doi.org/10.1111/cas.14761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935802/
https://www.ncbi.nlm.nih.gov/pubmed/33277750
http://dx.doi.org/10.1111/cas.14761

Ejemplares similares